Treatment
Drug clinical trials
We’re tracking 1,253 recruiting studies that include Drug, each written for real people, not researchers, below.
Recruiting studies
- NCT07853261Recruiting
Balloon inflation study for coronary stent placement
This trial tests a special way of inflating a balloon after placing a stent in a blocked heart artery. It aims to improve how well the stent expands, which may help keep the artery open.
Changchun, JilinAges 18 years+ - NCT07851623RecruitingPhase 1
Inhaled study drug for healthy adults and adults with asthma
This early-phase study tests an inhaled medication (CHF10136) to see if it's safe and how the body handles it. It includes both healthy adults and people with asthma, and participants will be monitored closely throughout.
LeedsAges 18–65 - NCT03979170Recruiting
Test lung cancer drug response using patient tumor mini-organs
This trial grows “organoids” (mini tumor models) from your lung cancer tissue to see which drug responses are most likely. It may help match future treatments to how your tumor behaves in the lab.
GenevaAges 18 years+ - NCT06455488Recruiting
Ventricular tachycardia management outcomes registry
This registry collects information about how ventricular tachycardia (a fast heart rhythm from the lower chambers) is managed and the results of different treatments. Participating can help improve future care.
Chicago, IllinoisAges 18 years+ - NCT04615065Recruiting
Biobank study collecting emergency data for very sick patients
This study collects health and sometimes blood sample information from people arriving at the emergency department with high-risk or serious conditions. The goal is to build a large emergency “biobank” to help researchers better understand and improve urgent care.
GroningenAges 18 years+ - NCT07838740RecruitingPhase 1
Weekly weight-loss medication for healthy adults with obesity
This early-stage trial tests a new once-weekly medication (VK2735) that may help with weight loss. It's for healthy adults with obesity who do not have other significant health problems like diabetes.
Lake Forest, CaliforniaAges 18–60 - NCT05811845Recruiting
Testing blood monitoring of 6MP to help kids stay in remission
This trial is for children newly diagnosed with acute lymphoblastic leukemia (ALL). It tests whether checking medicine levels in the blood can help optimize ongoing treatment (maintenance) and potentially keep the cancer under control.
Monza, Monza BrianzaAges Up to 18 years - NCT06371482RecruitingPhase 2
Durvalumab plus chemoradiation for limited-stage small cell lung cancer
This trial tests adding the immunotherapy drug durvalumab to standard chemotherapy and radiation for limited-stage small cell lung cancer. The goal is to see if this combination helps control the cancer better than standard treatment alone.
Shijiazhuang, HebeiAges 18–75 - NCT06463717Recruiting
Stem cell transplant timing for multiple myeloma with no cancer cells left
This trial looks at people with newly diagnosed multiple myeloma who have no detectable cancer cells after initial treatment. It aims to see if these patients can do well without a stem cell transplant or with a delayed one, reducing unnecessary side effects.
Hangzhou, ZhejiangAges 18–70 - NCT07833696Recruiting
Study of severe hives that don't respond to omalizumab
This study looks at people with severe hives (chronic urticaria) that have not improved with the usual dose of the medicine omalizumab. It aims to better understand these cases and how they are managed, which may help improve future care.
Besançon, Franche-comtéAges 18–80 - NCT03192501Recruiting
Using prior scans to guide cancer treatment choices
This trial tests whether using existing “PACS” scan images to guide individualized cancer treatment (compared with standard care) can improve outcomes for people with advanced or metastatic cancer. It may help doctors make more precise treatment decisions using your past imaging.
Guangzhou, GuangdongAges 18–70 - NCT07820891RecruitingPhase 1
Healthy volunteer study for BGB-43395 drug interactions
This study tests whether a new medicine, BGB-43395, interacts with other drugs in healthy people. It helps doctors understand how the drug is processed, which is important for future patients.
Dallas, TexasAges 18–65 - NCT06317558Recruiting
Real-world study of immunotherapy before surgery for lung cancer
This study looks at how well immunotherapy given before surgery works for non-small cell lung cancer. It aims to help doctors understand real-world outcomes for patients who receive this treatment.
Beijing, Beijing MunicipalityAges 18–85 - NCT06490029Recruiting
Hearing loss from cancer treatment: a diagnosis study
This study looks at hearing problems caused by cancer treatments that can damage the ears or nervous system. It aims to better understand and diagnose these side effects to help patients.
ParisAges 18 years+ - NCT07812831Enrolling by invitation
How health information changes over time
This study looks at how health information from people changes over time. The goal is to better understand normal patterns and spot when things change, which may help doctors improve care. You can join whether you have a medical condition or are generally healthy.
New York, New YorkAges 18 years+ - NCT07814118Enrolling by invitation
Understanding how your body works during routine care
This study looks at how different body systems work together in people with various conditions and healthy volunteers. It uses routine medical tests and data to understand health better, which can help improve future care.
New York, New YorkAges 18 years+ - NCT07814248RecruitingPhase 1
TS-104 for advanced solid tumors
This trial tests a new drug called TS-104 for people with certain advanced solid tumors that have stopped responding to standard treatments. The drug is given alone (not with other cancer treatments) to see if it can shrink tumors or slow their growth.
Maumee, OhioAges 18 years+ - NCT06207552RecruitingEarly Phase 1
Gene therapy study for children with Fabry disease
This study tests a new gene therapy for children aged 7 to 17 with Fabry disease. The treatment aims to fix the faulty gene that causes the condition, which may help reduce symptoms and prevent organ damage.
ShanghaiAges 7–18 - NCT05159245RecruitingPhase 2
Targeted drug access for adults with advanced cancer
This trial helps match people with advanced, hard-to-treat cancers to targeted cancer drugs based on lab testing of their tumor. It may help if standard treatment isn’t working or isn’t available, and if your tumor has a “targetable” genetic change.
Turku, Southwest FinlandAges 18–100 - NCT07802678RecruitingPhase 4
Stopping RA medicines in combination therapy
This study looks at whether people with rheumatoid arthritis who are stable on a TNF inhibitor plus another drug can safely stop the second drug. It aims to see if stopping the extra medicine keeps the disease under control and reduces side effects.
Nijmegen, GelderlandAges 18 years+ - NCT07808866Recruiting
Computer and expert review of medicine reactions
This trial uses computers and multiple experts to study adverse drug reactions. They want to compare how well machines and humans can predict a dangerous reaction. If you have had a confirmed bad reaction to a medicine, your case may help improve future safety.
Beijing, Beijing MunicipalityAges Any age - NCT05609084Recruiting
Speech therapy before surgery for drug-resistant temporal epilepsy
This study tests an intensive pre-surgery speech rehabilitation program for people whose seizures come from the language-related area in the temporal part of the brain. The goal is to improve speech outcomes before planned epilepsy surgery.
BordeauxAges 16 years+ - NCT07800897RecruitingPhase 1
How a new drug reacts with food and other medicines in healthy women
This trial checks how a new experimental drug (called Navlimetostat) interacts with other medicines and how food affects it. Healthy women participate to help researchers find the right dose and safety, which could later help people with cancer.
Québec, QuebecAges 18–55 - NCT06527963Recruiting
Balloon types for fistula narrowing in dialysis patients
This trial compares two types of balloons used to open up narrowed areas in the blood vessels of dialysis patients. It aims to find which balloon works better for keeping the fistula working well.
Zhengzhou, HenanAges 18–75
Common questions
- Are there clinical trials studying Drug?
- Yes. Clin2 currently lists 1,253 recruiting studies that include Drug, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Drug trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Drug an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Drug or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.